[go: up one dir, main page]

WO2001010424A3 - Formation de cholesterol oxyde reduite grace aux acides gras polyinsatures de la serie n-3 et a la vitamine e - Google Patents

Formation de cholesterol oxyde reduite grace aux acides gras polyinsatures de la serie n-3 et a la vitamine e Download PDF

Info

Publication number
WO2001010424A3
WO2001010424A3 PCT/EP2000/007604 EP0007604W WO0110424A3 WO 2001010424 A3 WO2001010424 A3 WO 2001010424A3 EP 0007604 W EP0007604 W EP 0007604W WO 0110424 A3 WO0110424 A3 WO 0110424A3
Authority
WO
WIPO (PCT)
Prior art keywords
pufa
vitamin
reducing cholesterol
cholesterol oxides
oxides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2000/007604
Other languages
German (de)
English (en)
Other versions
WO2001010424A2 (fr
Inventor
Klaus Kraemer
Tilmann Grune
Werner G Siems
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of WO2001010424A2 publication Critical patent/WO2001010424A2/fr
Publication of WO2001010424A3 publication Critical patent/WO2001010424A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La présente invention concerne l'utilisation d'acides gras polyinsaturés de la série n-3 et/ou de vitamine E dans le but de réduire la formation de cholestérol oxydé.
PCT/EP2000/007604 1999-08-05 2000-08-04 Formation de cholesterol oxyde reduite grace aux acides gras polyinsatures de la serie n-3 et a la vitamine e Ceased WO2001010424A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19936831.7 1999-08-05
DE19936831A DE19936831A1 (de) 1999-08-05 1999-08-05 Verringerung von Cholesterinoxiden durch n-3-PUFA und Vitamin E

Publications (2)

Publication Number Publication Date
WO2001010424A2 WO2001010424A2 (fr) 2001-02-15
WO2001010424A3 true WO2001010424A3 (fr) 2001-07-05

Family

ID=7917235

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/007604 Ceased WO2001010424A2 (fr) 1999-08-05 2000-08-04 Formation de cholesterol oxyde reduite grace aux acides gras polyinsatures de la serie n-3 et a la vitamine e

Country Status (2)

Country Link
DE (1) DE19936831A1 (fr)
WO (1) WO2001010424A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ539624A (en) * 2002-09-27 2008-08-29 Martek Biosciences Corp Prophylactic docosahexaenoic acid therapy for patients with subclinical inflammation
CN104938816A (zh) * 2015-06-02 2015-09-30 广西壮族自治区水牛研究所 一种能降低水牛机体胆固醇的饲粮
CN104982713A (zh) * 2015-06-15 2015-10-21 广西壮族自治区水牛研究所 一种能提高水牛机体高密度脂蛋白胆固醇的饲粮
DE102022003441A1 (de) 2022-09-17 2024-03-28 Jutta Ibrahim Nahrungsergänzungsmittel Omega3 und essentielle Aminosäure(n)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133963A (en) * 1990-12-21 1992-07-28 Shuntaro Ise Method of producing commercially useful poultry products with increased concentrations of Omega-3 polyunsaturated fatty acids
WO1993011675A1 (fr) * 1991-12-10 1993-06-24 Simanol A/S Produit comestible et procede de preparation
DE19629433A1 (de) * 1996-07-22 1998-01-29 Hoechst Ag Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier
EP0843972A1 (fr) * 1996-11-20 1998-05-27 N.V. Nutricia Composition nutritionnelle comprenant des graisses pour le traitement du syndrome métabolique
WO2000044237A2 (fr) * 1999-01-29 2000-08-03 Brandeis University Hyperabsorption de la vitamine e dispersee dans des laits

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5133963A (en) * 1990-12-21 1992-07-28 Shuntaro Ise Method of producing commercially useful poultry products with increased concentrations of Omega-3 polyunsaturated fatty acids
WO1993011675A1 (fr) * 1991-12-10 1993-06-24 Simanol A/S Produit comestible et procede de preparation
DE19629433A1 (de) * 1996-07-22 1998-01-29 Hoechst Ag Omega-3-fettsäurenenthaltende Zubereitung aus Mikroorganismen als Prophylaktikum bzw. Therapeutikum gegen parasitäre Erkrankungen beim Tier
EP0843972A1 (fr) * 1996-11-20 1998-05-27 N.V. Nutricia Composition nutritionnelle comprenant des graisses pour le traitement du syndrome métabolique
WO2000044237A2 (fr) * 1999-01-29 2000-08-03 Brandeis University Hyperabsorption de la vitamine e dispersee dans des laits

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
BUCKLEY D J ET AL: "Influence of dietary vitamin E on the oxidative stability and quality of pig meat.", JOURNAL OF ANIMAL SCIENCE 1995 DEP. OF FOOD TECH., UNIV. COLL., CORK, REPUBLIC OF IRELAND, vol. 73, no. 10, pages 3122 - 3130, XP000978589 *
DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; Database accession no. 95156795 *
FOULON T ET AL: "Effects of fish oil fatty acids on plasma lipids and lipoproteins and oxidant - Antioxidant imbalance in healthy subjects.", SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION, vol. 59, no. 4, July 1999 (1999-07-01), pages 239 - 248, XP000978457, ISSN: 0036-5513 *
GARCIA D J: "OMEGA-3 LONG-CHAIN PUFA NUTRACEUTICALS", FOOD TECHNOLOGY,US,INSTITUTE OF FOOD TECHNOLOGISTS. CHICAGO, vol. 52, no. 6, 1 June 1998 (1998-06-01), pages 44 - 49, XP000771913, ISSN: 0015-6639 *
MATA P ET AL: "Monounsaturated and polyunsaturated n-6 fatty acid enriched diets modify LDL oxidation and decrease human coronary smooth muscle cell DNA synthesis.", ARTERIOSCLEROSIS, vol. 17, no. 10, 1997, THE ASSOCIATION, DALLAS,TX, US, pages 2088 - 2095, XP000980624, ISSN: 0276-5047 *
MEYDANI M: "VITAMIN E", LANCET THE,LANCET LIMITED. LONDON,GB, vol. 345, no. 8943, 21 January 1995 (1995-01-21), pages 170 - 175, XP000953041, ISSN: 0140-6736 *
PANZETTA O ET AL: "Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: Effects of fish oil and vitamin E administration.", CLINICAL NEPHROLOGY, vol. 44, no. 6, 1995, pages 303 - 309, XP000980133, ISSN: 0301-0430 *
YOSHIDA H ET AL: "Modified low-density protein", JAPANESE JOURNAL OF CLINICAL MEDICINE - NIPPON RINSHO., vol. 52, no. 12, 95156795, 1994, NIPPON-RINSHO CO., OSAKA., JP, pages 3090 - 3095, XP000978442, ISSN: 0047-1852 *

Also Published As

Publication number Publication date
DE19936831A1 (de) 2001-02-08
WO2001010424A2 (fr) 2001-02-15

Similar Documents

Publication Publication Date Title
AU2001245401A1 (en) Hydrazones and analogs as cholesterol lowering agents
AU1085901A (en) Improved restraint-type differential relay
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2001253411A1 (en) Medical dressing assembly and associated method of using the same
AU2002216470A1 (en) Cholesterol lowering supplement
AU6099100A (en) Ultra-rugged i.c. sensor and method of making the same
NZ514350A (en) Compositions and methods for effecting the levels of cholesterol
AU2001240115A1 (en) Method for the preparation of tetrahydrobenzothiepines
AU2002364528A1 (en) Bio-implant and method of making the same
AU2001277008A1 (en) Online reactivation of an account or service
AU2001247782A1 (en) 18221, dual specificity phosphatase and uses thereof
AU2001245288A1 (en) Overhanging form system and method of using the same
AUPQ958400A0 (en) Validation of transactions
WO2001027118A3 (fr) Derives d'imidazo-5-yl-amine bicycliques
AU5111800A (en) Method of operating freight market over the internet
AU2002225894A1 (en) Methods and compositions for the control of coccidiosis
AU2002230606A1 (en) Glazing unit and method of making the same
AU2001281307A1 (en) Fluorescein-based metal sensors, and methods of making and using the same
AU2001260774A1 (en) Bio-support and preparing method of the same
WO2001066144A3 (fr) Therapie d'association de medicaments
AUPQ885500A0 (en) Enhancement of products
AU2002239258A1 (en) Houttuyninum compositions and methods for inhibiting the activity of erbb-2 based thereon
AU2001234178A1 (en) Modified bdnf
AU2001264522A1 (en) Methods and compositions for the prevention of myopia
WO2001010424A3 (fr) Formation de cholesterol oxyde reduite grace aux acides gras polyinsatures de la serie n-3 et a la vitamine e

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CN JP RO SI US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): CN JP RO SI US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WA Withdrawal of international application